病理に基づく髄膜腫の治療方針

DOI 参考文献19件
  • 岡 秀宏
    北里大学医学部脳神経外科 Departments of Laboratory Medicine & Pathology, Mayo Clinic and Mayo Medical School, U. S. A
  • Arie Perry
    Department of Pathology, University of California, San Francisco, U. S. A
  • Bernd W. Scheithauer
    Departments of Laboratory Medicine & Pathology, Mayo Clinic and Mayo Medical School, U. S. A

書誌事項

タイトル別名
  • Treatment Strategy of Meningiomas based on the Pathological Diagnosis

この論文をさがす

説明

  Meningioma is a meningothelial (arachnoidal) cell neoplasm, typically attached to the inner surface of the dura mater. Most meningiomas are benign and correspond to WHO grade I. Certain histological subtypes or meningiomas with specific combinations of morphologic parameters are associated with less favourable clinical outcomes and correspond to WHO grade II, including chordoid, clear cell, and atypical meningiomas, and grade III, including papillary, rhabdoid, and anaplastic meningiomas. The treatment strategy for meningiomas is total removal. While benign meningiomas have recurrence rates of about 7-25%, WHO grade II meningiomas recur in 29-52% of cases and grade III meningiomas at rates of 50-94%. Thus, radiotherapy for grade II and III meningiomas after tumor removal may be needed.

収録刊行物

参考文献 (19)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ